The Pharmaceutical Supply Chain
BRG is home to renowned thought leaders and experts considered authorities in their fields of work. Our timely research and perspectives provide analysis and insights on the most important issues facing the industries and organizations we serve.
Gross Drug Expenditures Realized by Stakeholders
Within the US healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees—some of which are paid after a prescription drug is dispensed to the patient.
In this study, Aaron Vandervelde and Eleanor Blalock discuss the drug distribution and payment process and estimate the share of gross and net drug expenditures realized by manufacturers and other entities along the supply chain.
Read the January 2020 update.
Read the original paper and the executive summary.
This study was funded by the Pharmaceutical Research and Manufacturers of America.
Related Professionals
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.